"
Team:UCL/Background/Alzheimers
From 2013.igem.org
(Difference between revisions)
| Line 42: | Line 42: | ||
<div class="full_page"> | <div class="full_page"> | ||
| + | |||
| + | <div class="main_image"></div> | ||
| + | |||
Over the last decade there has been mounting public interest in the emergence of genetic modification (GM) technologies, and a great deal of thought has been devoted to determining its risks, rewards, and overall impacts on society. These technologies promise a great deal, perhaps even treatments for brain diseases, such as Alzheimer's, where more conventional approaches have hit a dead end.Over the last decade there has been mounting public interest in the emergence of genetic modification (GM) technologies, and a great deal of thought has been devoted to determining its risks, rewards, and overall impacts on society. These technologies promise a great deal, perhaps even treatments for brain diseases, such as Alzheimer's, where more conventional approaches have hit a dead end.Over the last decade there has been mounting public interest in the emergence of genetic modification (GM) technologies, and a great deal of thought has been devoted to determining its risks, rewards, and overall impacts on society. These technologies promise a great deal, perhaps even treatments for brain diseases, such as Alzheimer's, where more conventional approaches have hit a dead end. | Over the last decade there has been mounting public interest in the emergence of genetic modification (GM) technologies, and a great deal of thought has been devoted to determining its risks, rewards, and overall impacts on society. These technologies promise a great deal, perhaps even treatments for brain diseases, such as Alzheimer's, where more conventional approaches have hit a dead end.Over the last decade there has been mounting public interest in the emergence of genetic modification (GM) technologies, and a great deal of thought has been devoted to determining its risks, rewards, and overall impacts on society. These technologies promise a great deal, perhaps even treatments for brain diseases, such as Alzheimer's, where more conventional approaches have hit a dead end.Over the last decade there has been mounting public interest in the emergence of genetic modification (GM) technologies, and a great deal of thought has been devoted to determining its risks, rewards, and overall impacts on society. These technologies promise a great deal, perhaps even treatments for brain diseases, such as Alzheimer's, where more conventional approaches have hit a dead end. | ||
</div> | </div> | ||
Revision as of 17:02, 14 August 2013
Over the last decade there has been mounting public interest in the emergence of genetic modification (GM) technologies, and a great deal of thought has been devoted to determining its risks, rewards, and overall impacts on society. These technologies promise a great deal, perhaps even treatments for brain diseases, such as Alzheimer's, where more conventional approaches have hit a dead end.Over the last decade there has been mounting public interest in the emergence of genetic modification (GM) technologies, and a great deal of thought has been devoted to determining its risks, rewards, and overall impacts on society. These technologies promise a great deal, perhaps even treatments for brain diseases, such as Alzheimer's, where more conventional approaches have hit a dead end.Over the last decade there has been mounting public interest in the emergence of genetic modification (GM) technologies, and a great deal of thought has been devoted to determining its risks, rewards, and overall impacts on society. These technologies promise a great deal, perhaps even treatments for brain diseases, such as Alzheimer's, where more conventional approaches have hit a dead end.
